| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.16 | 0.4 |